Nanoparticles, medtech & aging
We invest across biotechnology and medical technology, with strategic focus on three key areas: nanoparticle-based therapeutics, innovative medical devices, and longevity science.
Nanoparticle Technologies
Nanoparticles are revolutionizing drug delivery, diagnostics, and therapeutics. We're particularly excited about lipid nanoparticles (LNPs), polymeric systems, and inorganic nanocarriers.
LNPs, exosomes, and targeted carriers for RNA and gene therapies
Tumor-targeting nanoparticles and tissue-specific delivery
Quantum dots and contrast agents for imaging and detection
Medical Technology
We back innovative medical devices and technologies that improve patient outcomes, reduce healthcare costs, and transform clinical practice.
Implantables, surgical robotics, and next-gen diagnostics
Wearables, continuous sensors, and connected health platforms
Minimally invasive tools and AI-assisted procedures
Aging & Longevity
We're excited about the science of aging and companies working to extend healthspan. From senolytics to cellular reprogramming, this field is poised for breakthroughs.
Reprogramming, senolytics, and mitochondrial therapies
Epigenetic clocks, proteomics, and biological age testing
Interventions targeting age-related decline and disease prevention
Therapeutics
Biologics, small molecules, cell and gene therapies with clear paths to clinical proof.
Platform Biotech
Repeatable discovery engines and scalable production technologies.
AI × Healthcare
Machine learning for drug discovery and clinical decision support.
Medical Devices
Innovative devices and surgical technologies improving outcomes.
Diagnostics
Point-of-care testing, liquid biopsy, and precision medicine tools.
Digital Health
Remote monitoring and software that improves care delivery.